Skip Nav Destination
Issues
15 August 2018
-
Cover Image
Cover Image
The cover shows INFγ production by activated T cells in a section of biopsied tumor tissue. Tissue sections were probed for IFNγ expression (brown foci) using RNAscope and costained for CD3 expression (red foci) using immunohistochemistry. Representative images are from a clear cell sarcoma tumor treated with two injections of 6-million aDCs/injection. For details, see the article by Subbiah and colleagues on page 3845 of this issue. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1078-0432
EISSN 1557-3265
Highlights
CCR Translations
Reviews
Perspectives
Clinical Trials: Targeted Therapy
Author Choice
Andecaliximab/GS-5745 Alone and Combined with mFOLFOX6 in Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: Results from a Phase I Study
Manish A. Shah; Alexander Starodub; Sunil Sharma; Jordan Berlin; Manish Patel; Zev A. Wainberg; Jorge Chaves; Michael Gordon; Kevin Windsor; Carrie Baker Brachmann; Xi Huang; Greg Vosganian; Julia D. Maltzman; Victoria Smith; Jeffrey A. Silverman; Heinz-Josef Lenz; Johanna C. Bendell
Clinical Trials: Immunotherapy
Author Choice
Cytokines Produced by Dendritic Cells Administered Intratumorally Correlate with Clinical Outcome in Patients with Diverse Cancers
Vivek Subbiah; Ravi Murthy; David S. Hong; Robert M. Prins; Chitra Hosing; Kyle Hendricks; Deepthi Kolli; Lori Noffsinger; Robert Brown; Mary McGuire; Siquing Fu; Sarina Piha-Paul; Aung Naing; Anthony P. Conley; Robert S. Benjamin; Indreshpal Kaur; Marnix L. Bosch
Precision Medicine and Imaging
Undifferentiated Sarcomas in Children Harbor Clinically Relevant Oncogenic Fusions and Gene Copy-Number Alterations: A Report from the Children's Oncology Group
Theodore W. Laetsch; Angshumoy Roy; Lin Xu; Jennifer O. Black; Cheryl M. Coffin; Yueh-Yun Chi; Jing Tian; Sheri L. Spunt; Douglas S. Hawkins; Julia A. Bridge; D. Williams Parsons; Stephen X. Skapek
Identification and Validation of Radiographic Enhancement for Reliable Differentiation of CD117(+) Benign Renal Oncocytoma and Chromophobe Renal Cell Carcinoma
Jay Amin; Bo Xu; Shervin Badkhshan; Terrance T. Creighton; Daniel Abbotoy; Christine Murekeyisoni; Kristopher M. Attwood; Thomas Schwaab; Craig Hendler; Michael Petroziello; Charles L. Roche; Eric C. Kauffman
Author Choice
Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical Prostatectomy
R. Jeffrey Karnes; Vidit Sharma; Voleak Choeurng; Hussam Al-Deen Ashab; Nicholas Erho; Mohammed Alshalalfa; Bruce Trock; Ashley Ross; Kasra Yousefi; Harrison Tsai; Shuang G. Zhao; Jeffrey J. Tosoian; Zaid Haddad; Mandeep Takhar; S. Laura Chang; Daniel E. Spratt; Firas Abdollah; Robert B. Jenkins; Eric A. Klein; Paul L. Nguyen; Adam P. Dicker; Robert B. Den; Elai Davicioni; Felix Y. Feng; Tamara L. Lotan; Edward M. Schaeffer
Translational Cancer Mechanisms and Therapy
Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma
Joseph J. Caumanns; Katrien Berns; G. Bea A. Wisman; Rudolf S.N. Fehrmann; Tushar Tomar; Harry Klip; Gert J. Meersma; E. Marielle Hijmans; Annemiek M.C. Gennissen; Evelien W. Duiker; Desiree Weening; Hiroaki Itamochi; Roelof J.C. Kluin; Anna K.L. Reyners; Michael J. Birrer; Helga B. Salvesen; Ignace Vergote; Els van Nieuwenhuysen; James Brenton; E. Ioana Braicu; Jolanta Kupryjanczyk; Beata Spiewankiewicz; Lorenza Mittempergher; René Bernards; Ate G.J. van der Zee; Steven de Jong
Combined HDAC and Bromodomain Protein Inhibition Reprograms Tumor Cell Metabolism and Elicits Synthetic Lethality in Glioblastoma
Yiru Zhang; Chiaki Tsuge Ishida; Wataru Ishida; Sheng-Fu L. Lo; Junfei Zhao; Chang Shu; Elena Bianchetti; Giulio Kleiner; Maria J. Sanchez-Quintero; Catarina M. Quinzii; Mike-Andrew Westhoff; Georg Karpel-Massler; Peter Canoll; Markus D. Siegelin
Author Choice
Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell Lymphomas
Lan V. Pham; Shengjian Huang; Hui Zhang; Jun Zhang; Taylor Bell; Shouhao Zhou; Elizabeth Pogue; Zhiyong Ding; Laura Lam; Jason Westin; R. Eric Davis; Ken H. Young; L. Jeffrey Medeiros; Richard J. Ford; Krystle Nomie; Leo Zhang; Michael Wang
Aberrant Lck Signal via CD28 Costimulation Augments Antigen-Specific Functionality and Tumor Control by Redirected T Cells with PD-1 Blockade in Humanized Mice
Pratiksha Gulati; Julia Rühl; Abhilash Kannan; Magdalena Pircher; Petra Schuberth; Katarzyna J. Nytko; Martin Pruschy; Simon Sulser; Mark Haefner; Shawn Jensen; Alex Soltermann; Wolfgang Jungraithmayr; Maya Eisenring; Thomas Winder; Panagiotis Samaras; Annett Tabor; Rene Stenger; Roger Stupp; Walter Weder; Christoph Renner; Christian Münz; Ulf Petrausch
The Highly Metastatic Nature of Uterine Cervical/Endometrial Cancer Displaying Tumor-Related Leukocytosis: Clinical and Preclinical Investigations
Tomoyuki Sasano; Seiji Mabuchi; Katsumi Kozasa; Hiromasa Kuroda; Mahiru Kawano; Ryoko Takahashi; Naoko Komura; Eriko Yokoi; Yuri Matsumoto; Kae Hashimoto; Kenjiro Sawada; Eiichi Morii; Tadashi Kimura
Metformin Targets Mitochondrial Glycerophosphate Dehydrogenase to Control Rate of Oxidative Phosphorylation and Growth of Thyroid Cancer In Vitro and In Vivo
Shilpa Thakur; Brianna Daley; Kelli Gaskins; Vasyl V. Vasko; Myriem Boufraqech; Dhaval Patel; Carole Sourbier; Jeff Reece; Sheue-Yann Cheng; Electron Kebebew; Sunita Agarwal; Joanna Klubo-Gwiezdzinska
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.